市場調查報告書
商品編碼
1331409
植物性輔料市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機遇和預測,按類型、按應用、地區和競爭細分Plant Based Excipients Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Type, By Application, By Region and Competition |
由於包括製藥在內的各行業對天然和永續產品的需求不斷成長,全球植物性輔料市場預計在預測期內將以令人印象深刻的速度成長。植物性輔料被視為比傳統輔料更永續、更環保的替代品,傳統輔料通常源自石油等不可再生來源。消費者越來越關注產品對環境的影響,並尋求更永續的替代品。全球消費者和政府將焦點轉向永續發展,預計將為未來幾年全球植物性輔料市場的成長創造新的前景。
近年來,植物性賦形劑在藥物製劑中的使用越來越受到關注。這是由於對藥品中天然、永續和安全成分的需求不斷成長。與傳統賦形劑相比,植物性賦形劑具有多種優點,包括更好的溶解度、更高的生物利用度和更低的毒性。為了支持植物性輔料的發展,已經制定了幾項有利的法規。這些法規鼓勵在藥品中使用天然和永續成分,並促進創新植物輔料的開發。 FDA 的 GRAS(公認安全)清單是被認為可安全用於食品和藥品的物質清單。該列表包括幾種植物性賦形劑,例如纖維素、澱粉和果膠。將這些輔料列入 GRAS 清單鼓勵了它們在藥物製劑中的使用,因為它們被認為是安全的,不需要進行廣泛的安全測試。反過來,預計這將為全球植物性輔料市場的成長創造利潤豐厚的機會。此外,歐洲藥典是歐洲藥品的一套標準和指南。藥典包括幾部關於植物性賦形劑的專著,例如微晶纖維素、澱粉和乳糖。這些專著提供了有關這些賦形劑的品質和規格的詳細資訊,這鼓勵了它們在藥物製劑中的使用。此外,國際藥用輔料理事會 (IPEC) 還提供有關藥用輔料(包括植物性輔料)的品質和安全性的指南。這些指南確保植物性輔料符合藥品中使用的必要品質標準。這種支持性的監管環境預計將在未來幾年促進全球植物性輔料市場的成長。
多年來,由於植物輔料的成本效益和對患者健康的不良反應較小,與植物輔料相關的研究顯著增加。近年來,植物性輔料作為製藥行業傳統輔料的更永續、更環保的替代品而受到廣泛關注。因此,人們對植物性輔料的特性和應用進行了大量的研究,從而為全球植物性輔料市場的成長創造了新的前景。例如,海藻酸鹽是一種從褐海藻中提取的多醣,已被用作藥物賦形劑。最近的研究重點是開發基於藻酸鹽的賦形劑,可用於提高難溶性藥物的溶解度和生物利用度。基於藻酸鹽的賦形劑還被發現具有粘膜粘附特性,使其適合用於針對體內特定部位的藥物遞送系統。同樣,纖維素是一種存在於植物中的天然聚合物,已被用作藥物的賦形劑。最近的研究重點是開發可用於提高藥物穩定性和溶解度的纖維素基賦形劑。人們還發現基於纖維素的賦形劑具有抗氧化特性,使其適合用於開發針對氧化壓力相關疾病的藥物。
總之,最近的研究重點是開發可用於提高藥物的溶解度、穩定性和生物利用度的植物性賦形劑。海藻酸鹽、纖維素、澱粉、蛋白質和樹膠等植物性賦形劑在製藥行業的各種應用中顯示出良好的前景。隨著該領域研究的不斷推進,預計將開發出更多植物性輔料並用於新藥的開發,從而支持全球植物性輔料市場的成長。
根據給定的市場數據,TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項:
Global Plant Based Excipients Market is expected to grow at an impressive rate during the forecast period on account of the growing demand for natural and sustainable products in various industries, including pharmaceuticals. Plant-based excipients are seen as a more sustainable and eco-friendlier alternative to traditional excipients, which are often derived from non-renewable sources such as petroleum. Consumers are increasingly concerned about the environmental impact of products and are seeking more sustainable alternatives. The shifting focus of consumers and governments across the globe towards sustainability is expected to create new prospects for the growth of global plant based excipients market in the coming years.
Plant based excipients are derived from natural sources such as algae, starches, cellulose, gums, and proteins and are used to improve the stability, solubility, and bioavailability of drugs. Plant based excipients are considered safer than traditional excipients because they are derived from natural sources and are less likely to cause adverse reactions in patients. In addition, plant based excipients are free from potential contaminants and impurities that may be present in synthetic excipients. This, in turn, is expected to drive the growth of global plant based excipients market during the forecast period.
There has been a growing trend towards using plant based excipients in combination with other natural ingredients. For example, Hydroxy Propyl Methyl Cellulose (HPMC), a widely used plant based excipient, has been combined with natural gums such as guar gum, xanthan gum, and locust bean gum to improve tablet hardness and disintegration. This approach has resulted in a more natural and sustainable product while maintaining the required quality and efficacy of the drug. This, in turn, is expected to spur the demand for plant based excipients thereby driving the growth of global plant based excipients market in the next few years.
In recent years, there has been an increasing focus on the use of plant-based excipients in pharmaceutical formulations. This is due to the growing demand for natural, sustainable, and safe ingredients in pharmaceutical products. Plant-based excipients offer several benefits over traditional excipients, including better solubility, improved bioavailability, and reduced toxicity. To support the growth of plant-based excipients, there have been several favorable regulations put in place. These regulations encourage the use of natural and sustainable ingredients in pharmaceuticals and promote the development of innovative plant-based excipients. The FDA's GRAS (Generally Recognized as Safe) list is a list of substances that are considered safe for use in food and pharmaceutical products. The list includes several plant-based excipients such as cellulose, starch, and pectin. The inclusion of these excipients on the GRAS list has encouraged their use in pharmaceutical formulations, as they are considered safe and do not require extensive safety testing. This, in turn, is expected to create lucrative opportunities for the growth of global plant-based excipients market. Additionally, The European Pharmacopoeia is a set of standards and guidelines for pharmaceutical products in Europe. The pharmacopeia includes several monographs on plant-based excipients, such as microcrystalline cellulose, starch, and lactose. These monographs provide detailed information on the quality and specifications of these excipients, which has encouraged their use in pharmaceutical formulations. Also, the International Pharmaceutical Excipients Council (IPEC) provides guidelines on the quality and safety of pharmaceutical excipients, including plant-based excipients. These guidelines ensure that plant-based excipients meet the necessary quality standards for use in pharmaceutical products. Such a supportive regulatory environment is expected to foster the growth of global plant-based excipients market in the coming years.
Over the years, research related to plant based excipients has significantly increased on account of their cost-effectiveness and lesser adverse reactions to patient health. Plant based excipients have gained a lot of attention in recent years as a more sustainable and eco-friendlier alternative to traditional excipients in the pharmaceutical industry. As a result, there has been a significant amount of research conducted on the properties and applications of plant-based excipients, thereby creating new prospects for the growth of global plant based excipients market. For instance, alginate is a polysaccharide that is derived from brown seaweed and has been used as an excipient in pharmaceuticals. Recent research has focused on the development of alginate-based excipients that can be used to improve the solubility and bioavailability of poorly water-soluble drugs. Alginate-based excipients have also been found to have mucoadhesive properties, making them suitable for use in drug-delivery systems that target specific sites in the body. Similarly, cellulose is a natural polymer that is found in plants and has been used as an excipient in pharmaceuticals. Recent research has focused on the development of cellulose-based excipients that can be used to improve the stability and solubility of drugs. Cellulose-based excipients have also been found to have antioxidant properties, making them suitable for use in the development of drugs that target oxidative stress-related diseases.
In conclusion, recent research has focused on the development of plant-based excipients that can be used to improve the solubility, stability, and bioavailability of drugs. Plant-based excipients such as alginate, cellulose, starch, proteins, and gums have shown promise in various applications in the pharmaceutical industry. As research in this field continues to advance, it can be expected that more plant based excipients will be developed and used in the development of new drugs, thereby supporting the growth of global plant based excipients market.
Global Plant Based Excipients Market can be segmented by type, application, and by region. Based on type, the Global Plant Based Excipients market can be categorized into carbohydrates, proteins, polymers, minerals, glycoside & waxes, esters, and others. By application, the Global Plant Based Excipients market can be fragmented into binders & diluents, glidants, lubricants & disintegrants, film forming & coating agents, plasticizers, suspending agents, and others. Regionally, the Global Plant Based Excipients market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. Among different countries, United States is expected to dominate the global plant based excipients market. In the United States, there has been a growing interest in plant based excipients due to the increasing demand for natural and sustainable ingredients. The FDA has recognized many plant-based excipients as Generally Recognized as Safe (GRAS) for use in pharmaceuticals. The use of plant-based excipients in cosmetics is also gaining popularity due to the trend toward natural and organic products. This, in turn, will support the growth of plant based excipients market.
Roquette Freres SA, EVONIK Industries, Inc., DFE Pharma GmbH & Co.KG, Lonza Group, BASF SE, Novartis International AG, FMC Corporation, JRS Pharma LP, among others, are some of the leading players operating in the Global Plant Based Excipients market.
In this report, Global Plant Based Excipients Market has been segmented into following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Global Plant Based Excipients Market.
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: